1-3 of 3
Laurie Lisak
Close
Sort by
Journal Articles

Arsenic Trioxide (Trisenox®) with/without Thalidomide in Patients with Myelodysplastic Syndromes (MDS) Produces Hematologic Improvement (HI).

Azra Raza, M.D, Laurie Lisak, P.A.C, Jennifer Billmeier, P.A.C, Samreen Akbar, M.D, Khalid Washeed, M.D, Mohammad Mumtaz, B.A, Poluru Reddy, Ph.D, Naomi Galili, Ph.D
Journal: Blood
Blood (2004) 104 (11): 4710.
https://doi.org/10.1182/blood.V104.11.4710.4710
Published: 2004
Journal Articles

Thalidomide produces transfusion independence in long-standing refractory anemias of patients with myelodysplastic syndromes

Clinical Trials & Observations
Azra Raza, Peter Meyer, Diya Dutt, Francesca Zorat, Laurie Lisak, Fabiana Nascimben, Morne du Randt, Christopher Kaspar, Cathryn Goldberg, Jerome Loew, Saleem Dar, Sefer Gezer, Parameswaran Venugopal, Jerome Zeldis
Journal: Blood
Blood (2001) 98 (4): 958–965.
https://doi.org/10.1182/blood.V98.4.958
Published: 2001
Journal Articles

Patients with myelodysplastic syndromes benefit from palliative therapy with amifostine, pentoxifylline, and ciprofloxacin with or without dexamethasone

Azra Raza, Huma Qawi, Laurie Lisak, Tanja Andric, Saleem Dar, Colleen Andrews, Paramesuaran Venugopal, Sefer Gezer, Stephanie Gregory, Jerome Loew, Erwin Robin, Shelby Rifkin, Wei-Tong Hsu, Ray-Win Huang
Journal: Blood
Blood (2000) 95 (5): 1580–1587.
https://doi.org/10.1182/blood.V95.5.1580.005k45_1580_1587
Published: 2000